HRMY
HRMY
NASDAQ · Pharmaceuticals

Harmony Biosciences Holdings

$34.45
+0.29 (+0.85%)
As of Jun 24, 10:01 PM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 11 65%
Hold 5 29%
Sell 1 6%
Price Target
Analyst Price Target +171.5% upside
Low Target $67.60
Average Target $93.52
High Target $113.52
Current Price $34.45
Current
$34.45
Target
$93.52
$67.60 $93.52 avg $113.52
Scenario Analysis
Bear Case
$67.60
96.2%
Low target
Base Case
$93.52
+171.5%
Avg target
Bull Case
$113.52
+229.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$40.87
-15.7% from high
52-Week Low
$25.52
+35.0% from low
50-Day SMA
$37.42
-7.9% vs SMA
200-Day SMA
$34.21
+0.7% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$93.52
+128.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%